Voltage-Gated Sodium Channels in Drug Discovery
Open Access
- 10 October 2018
- book chapter
- Published by IntechOpen
Abstract
Voltage-gated sodium channels (Nav) control the initiation and propagation of action potential, and thus mediate a broad spectrum of physiological processes, including central and peripheral nervous systems’ function, skeletal muscle contraction, and heart rhythm. Recent advances in elucidating the molecular basis of channelopathies implicating Nav channels are the most appealing druggable targets for pain and many other pathology conditions. This chapter overviews Nav super family from genetic evolution, distribution, human diseases/pathology association, highlighting the most recent structure function breakthrough. The second section will discuss current small and large Nav modulators, including traditional nonselective pore blockers, intracellular modulators, and extracellular modulators.Keywords
This publication has 121 references indexed in Scilit:
- Grayanotoxin Poisoning: ‘Mad Honey Disease’ and BeyondCardiovascular Toxicology, 2012
- Structure of a bacterial voltage-gated sodium channel pore reveals mechanisms of opening and closingNature Communications, 2012
- The crystal structure of a voltage-gated sodium channelNature, 2011
- μ-Conotoxins that differentially block sodium channels NaV1.1 through 1.8 identify those responsible for action potentials in sciatic nerveProceedings of the National Academy of Sciences, 2011
- Targeting voltage sensors in sodium channels with spider toxinsTrends in Pharmacological Sciences, 2010
- Sea anemone toxins affecting voltage-gated sodium channels – molecular and evolutionary featuresToxicon, 2009
- Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humansNature Medicine, 2009
- A-803467, a potent and selective Na v 1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the ratProceedings of the National Academy of Sciences, 2007
- Voltage-gated sodium channel modulation by scorpion α-toxinsToxicon, 2007
- How many drug targets are there?Nature Reviews Drug Discovery, 2006